Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls

anon79999497 · August 19, 2015, 10:29am

ncbi.nlm.nih.gov

Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.

T Pawełczyk, E Trafalska, A Pawełczyk and M Kotlicka-Antczak, Early intervention in psychiatry, 2017 12

Supplementation with omega-3 PUFA showed efficacy in reducing the risk of transition into psychosis in UHR individuals. It is uncertain whether dietary patterns can be partly responsible for n-3 deficiencies observed in susceptible participants before the diagnosis of schizophrenia. The study was designed to assess differences in omega-3 and omega-6 PUFA consumption in healthy controls (HC), UHR participants and FES patients as well as to verify the hypothesis that dietary changes in PUFA consumption are present before active psychosis develops, that is, in UHR individuals.Dietary habits during the previous year were assessed in 34 patients at UHR of psychosis, 33 patients diagnosed with FES and 33 HC participants using a validated Food-Frequency Questionnaire and the Polish Food Composition Tables.Significant differences in omega-3 and omega-6 PUFA intake were observed between study groups. UHR and FES groups reported significantly higher consumption of omega-6 PUFA in comparison with HC. FES patients also reported a higher consumption of alpha-linolenic acid (omega-3) in comparison with HC. No significant differences were seen in consumption of long-chain marine PUFA.Differences in omega-6 and omega-3 PUFA consumption exist before development of psychotic symptoms, fulfilling the criteria of schizophrenia.

CONCLUSIONS:

Differences in omega-6 and omega-3 PUFA consumption exist before development of psychotic symptoms, fulfilling the criteria of schizophrenia.

anon93437440 · August 19, 2015, 11:07am

So what does that mean?

I am unable to draw any conclusion from it.

Topic		Replies	Views
Study Suggests Omega-3s May Not Improve Outcomes in People at High Risk of Psychosis News	2	615	November 23, 2016
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids News	1	356	January 19, 2015
Low levels of omega-3 associated with higher risk of psychosis, says study News	7	422	July 23, 2021
Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial News	1	40	October 25, 2024
Omega-3 fatty acid in ultra-high-risk psychosis: A systematic review based on functional outcome News	1	261	March 10, 2021

Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls

Related topics